Related references
Note: Only part of the references are listed.Comparative effectiveness of recombinant human follicle-stimulating hormone alfa (r-hFSH-alfa) versus highly purified urinary human menopausal gonadotropin (hMG HP) in assisted reproductive technology (ART) treatments: a non-interventional study in Germany
Klaus F. Buehler et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2021)
Proven and unproven methods for diagnosis and treatment of infertility
Marian Szamatowicz et al.
ADVANCES IN MEDICAL SCIENCES (2020)
ESHRE guideline:oval n s simulation for IVF/ICSI
Ernesto Bosch et al.
HUMAN REPRODUCTION OPEN (2020)
The Development of Gonadotropins for Clinical Use in the Treatment of Infertility
Bruno Lunenfeld et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Clinical adjuncts in in vitro fertilization: a growing list
Mohan S. Kamath et al.
FERTILITY AND STERILITY (2019)
Comparison of recombinant and urinary follicle-stimulating hormones over 2000 gonadotropin-releasing hormone antagonist cycles: a retrospective study
Wei Pan et al.
SCIENTIFIC REPORTS (2019)
Required amount of rFSH, HP-hMG and HP-FSH to reach a live birth: a systematic review and meta-analysis
E. M. Bordewijk et al.
HUMAN REPRODUCTION OPEN (2019)
Fertility and infertility: Definition and epidemiology
Melodie Vander Borght et al.
CLINICAL BIOCHEMISTRY (2018)
How do cumulative live birth rates and cumulative multiple live birth rates over complete courses of assisted reproductive technology treatment per woman compare among registries?
D. De Neubourg et al.
HUMAN REPRODUCTION (2016)
Cumulative live birth rates after one or more complete cycles of IVF: a population-based study of linked cycle data from 178 898 women
David J. McLernon et al.
HUMAN REPRODUCTION (2016)
The optimum number of oocytes in IVF treatment: an analysis of 2455 cycles in China
Jingjuan Ji et al.
HUMAN REPRODUCTION (2013)
Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles
Madelon van Wely et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2011)
Clinical efficacy of highly purified urinary FSH versus recombinant FSH in volunteers undergoing controlled ovarian stimulation for in vitro fertilization: a randomized, multicenter, investigator-blind trial
Valerie L. Baker et al.
FERTILITY AND STERILITY (2009)
Cumulative Live-Birth Rates after In Vitro Fertilization
Beth A. Malizia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Comparative assessment of the consistency and quality of a highly purified FSH extracted from human urine (urofollitropin) and a recombinant human FSH (follitropin α)
M. Lispi et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2006)
Recombinant versus highly-purified, urinary follicle-stimulating hormone (r-FSH vs. HP-uFSH) in ovulation induction: a prospective, randomized study with cost-minimization analysis
Alberto Revelli et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2006)
Improving the consistency of ovarian stimulation: follitropin alfa filled-by-mass
Matts Wikland et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2006)
Continued improvements in the quality and consistency of follitropin alfa, recombinant human FSH
R Bassett
REPRODUCTIVE BIOMEDICINE ONLINE (2005)
Effects of recombinant LH (rLH) supplementation during controlled ovarian hyperstimulation (COH) in normogonadotrophic women with an initial inadequate response to recombinant FSH (rFSH) after pituitary downregulation
G De Placido et al.
CLINICAL ENDOCRINOLOGY (2004)
Cumulative ovulation and pregnancy rates according to recombinant human follicle stimulating hormone (r-hFSH) dosing: Comparison of a new formulation of follitropin alfa in vials versus the standard formulation of follitropin alfa in ampules.
T Yeko et al.
FERTILITY AND STERILITY (2004)
What is the most relevant standard of success in assisted reproduction? The next step to improving outcomes of IVF: consider the whole treatment
EMEW Heijnen et al.
HUMAN REPRODUCTION (2004)
Assessment of the in vitro and in vivo biological activities of the human follicle-stimulating isohormones
J Barrios-De-Tomasi et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2002)